Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals

Carla J. Mathias, Michael R. Lewis, David E. Reichert, Richard Laforest, Terry L. Sharp, Jason S. Lewis, Zhen Fan Yang, David J. Waters, Paul W. Snyder, Philip S. Low, Michael J. Welch, Mark Green

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

A folate-receptor-targeting radiopharmaceutical, Ga(III)-deferoxamine-folate (Ga-DF-Folate), was radiolabeled with two positron-emitting isotopes of gallium, cyclotron-produced 66Ga (9.5 hour half-life) and generator-produced 68Ga (68 minute half-life). The [66Ga]Ga-DF-Folate was administered to athymic mice with folate-receptor-positive human KB cell tumor xenografts to demonstrate that microPET mouse tumor imaging is feasible with 66Ga, despite the relatively high positron energy of this radionuclide. Using the athymic mouse KB tumor xenograft model, dual-isotope autoradiography was also performed following i.v. co-administration of [18F]-FDG, a marker of regional metabolic activity, and folate-receptor-targeted [ 111In]In-DTPA-Folate. The autoradiographic images of 1 mm tumor sections demonstrate the gross heterogeneity of the KB cell tumor xenograft, as well as subtle disparity in the regional accumulation of the two radiotracers.

Original languageEnglish (US)
Pages (from-to)725-731
Number of pages7
JournalNuclear Medicine and Biology
Volume30
Issue number7
DOIs
StatePublished - Oct 2003
Externally publishedYes

Fingerprint

Deferoxamine
Radiopharmaceuticals
Folic Acid
Heterografts
KB Cells
Neoplasms
Gallium Isotopes
Nude Mice
Half-Life
Electrons
Cyclotrons
Fluorodeoxyglucose F18
Autoradiography
Radioisotopes
Isotopes

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals. / Mathias, Carla J.; Lewis, Michael R.; Reichert, David E.; Laforest, Richard; Sharp, Terry L.; Lewis, Jason S.; Yang, Zhen Fan; Waters, David J.; Snyder, Paul W.; Low, Philip S.; Welch, Michael J.; Green, Mark.

In: Nuclear Medicine and Biology, Vol. 30, No. 7, 10.2003, p. 725-731.

Research output: Contribution to journalArticle

Mathias, CJ, Lewis, MR, Reichert, DE, Laforest, R, Sharp, TL, Lewis, JS, Yang, ZF, Waters, DJ, Snyder, PW, Low, PS, Welch, MJ & Green, M 2003, 'Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals', Nuclear Medicine and Biology, vol. 30, no. 7, pp. 725-731. https://doi.org/10.1016/S0969-8051(03)00080-5
Mathias, Carla J. ; Lewis, Michael R. ; Reichert, David E. ; Laforest, Richard ; Sharp, Terry L. ; Lewis, Jason S. ; Yang, Zhen Fan ; Waters, David J. ; Snyder, Paul W. ; Low, Philip S. ; Welch, Michael J. ; Green, Mark. / Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals. In: Nuclear Medicine and Biology. 2003 ; Vol. 30, No. 7. pp. 725-731.
@article{4e05a4fa790e4bf78742688c5d5c3692,
title = "Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals",
abstract = "A folate-receptor-targeting radiopharmaceutical, Ga(III)-deferoxamine-folate (Ga-DF-Folate), was radiolabeled with two positron-emitting isotopes of gallium, cyclotron-produced 66Ga (9.5 hour half-life) and generator-produced 68Ga (68 minute half-life). The [66Ga]Ga-DF-Folate was administered to athymic mice with folate-receptor-positive human KB cell tumor xenografts to demonstrate that microPET mouse tumor imaging is feasible with 66Ga, despite the relatively high positron energy of this radionuclide. Using the athymic mouse KB tumor xenograft model, dual-isotope autoradiography was also performed following i.v. co-administration of [18F]-FDG, a marker of regional metabolic activity, and folate-receptor-targeted [ 111In]In-DTPA-Folate. The autoradiographic images of 1 mm tumor sections demonstrate the gross heterogeneity of the KB cell tumor xenograft, as well as subtle disparity in the regional accumulation of the two radiotracers.",
author = "Mathias, {Carla J.} and Lewis, {Michael R.} and Reichert, {David E.} and Richard Laforest and Sharp, {Terry L.} and Lewis, {Jason S.} and Yang, {Zhen Fan} and Waters, {David J.} and Snyder, {Paul W.} and Low, {Philip S.} and Welch, {Michael J.} and Mark Green",
year = "2003",
month = "10",
doi = "10.1016/S0969-8051(03)00080-5",
language = "English (US)",
volume = "30",
pages = "725--731",
journal = "Nuclear Medicine and Biology",
issn = "0969-8051",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals

AU - Mathias, Carla J.

AU - Lewis, Michael R.

AU - Reichert, David E.

AU - Laforest, Richard

AU - Sharp, Terry L.

AU - Lewis, Jason S.

AU - Yang, Zhen Fan

AU - Waters, David J.

AU - Snyder, Paul W.

AU - Low, Philip S.

AU - Welch, Michael J.

AU - Green, Mark

PY - 2003/10

Y1 - 2003/10

N2 - A folate-receptor-targeting radiopharmaceutical, Ga(III)-deferoxamine-folate (Ga-DF-Folate), was radiolabeled with two positron-emitting isotopes of gallium, cyclotron-produced 66Ga (9.5 hour half-life) and generator-produced 68Ga (68 minute half-life). The [66Ga]Ga-DF-Folate was administered to athymic mice with folate-receptor-positive human KB cell tumor xenografts to demonstrate that microPET mouse tumor imaging is feasible with 66Ga, despite the relatively high positron energy of this radionuclide. Using the athymic mouse KB tumor xenograft model, dual-isotope autoradiography was also performed following i.v. co-administration of [18F]-FDG, a marker of regional metabolic activity, and folate-receptor-targeted [ 111In]In-DTPA-Folate. The autoradiographic images of 1 mm tumor sections demonstrate the gross heterogeneity of the KB cell tumor xenograft, as well as subtle disparity in the regional accumulation of the two radiotracers.

AB - A folate-receptor-targeting radiopharmaceutical, Ga(III)-deferoxamine-folate (Ga-DF-Folate), was radiolabeled with two positron-emitting isotopes of gallium, cyclotron-produced 66Ga (9.5 hour half-life) and generator-produced 68Ga (68 minute half-life). The [66Ga]Ga-DF-Folate was administered to athymic mice with folate-receptor-positive human KB cell tumor xenografts to demonstrate that microPET mouse tumor imaging is feasible with 66Ga, despite the relatively high positron energy of this radionuclide. Using the athymic mouse KB tumor xenograft model, dual-isotope autoradiography was also performed following i.v. co-administration of [18F]-FDG, a marker of regional metabolic activity, and folate-receptor-targeted [ 111In]In-DTPA-Folate. The autoradiographic images of 1 mm tumor sections demonstrate the gross heterogeneity of the KB cell tumor xenograft, as well as subtle disparity in the regional accumulation of the two radiotracers.

UR - http://www.scopus.com/inward/record.url?scp=0141448741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141448741&partnerID=8YFLogxK

U2 - 10.1016/S0969-8051(03)00080-5

DO - 10.1016/S0969-8051(03)00080-5

M3 - Article

C2 - 14499330

AN - SCOPUS:0141448741

VL - 30

SP - 725

EP - 731

JO - Nuclear Medicine and Biology

JF - Nuclear Medicine and Biology

SN - 0969-8051

IS - 7

ER -